2017
DOI: 10.1016/j.cjca.2017.07.263
|View full text |Cite
|
Sign up to set email alerts
|

Modelling the Impact of Low-Density Lipoprotein Cholesterol Lowering With Alirocumab on Cardiovascular Event Reduction in Canada

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles